Assessing barriers to genomic testing in breast cancer among diverse patients: a qualitative community-engaged research study
{{output}}
Purpose: Genomic testing informs treatment decisions for estrogen receptor-positive, progesterone receptor-positive, and HER2-negative early-stage breast cancer, yet uptake remains disproportionately low among racially and ethnic... ...
